SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-005981
Filing Date
2022-04-22
Accepted
2022-04-22 08:05:59
Documents
12
Period of Report
2022-04-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K rare-20220418.htm   iXBRL 8-K 52059
  Complete submission text file 0000950170-22-005981.txt   166890

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rare-20220418.xsd EX-101.SCH 2501
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rare-20220418_lab.xml EX-101.LAB 12890
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rare-20220418_pre.xml EX-101.PRE 9549
6 EXTRACTED XBRL INSTANCE DOCUMENT rare-20220418_htm.xml XML 4518
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 22843426
SIC: 2834 Pharmaceutical Preparations